cycloplegic agent
Showing 1 - 25 of 6,222
Myopia, Myopia Progression, Juvenile Myopia Trial in United States (Spectacle Lenses)
Not yet recruiting
- Myopia
- +2 more
- Spectacle Lenses
-
Whittier, California
- +8 more
May 30, 2023
2WIN-S Portable Refractor Trial in Bangkok (2WIN-S portable refractor)
Active, not recruiting
- 2WIN-S Portable Refractor
- 2WIN-S portable refractor
-
Bangkok, ThailandRajavithi Hospital
Nov 20, 2023
Congenital Heart Disease, Children, Only Trial in London (OCTA measurements)
Not yet recruiting
- Congenital Heart Disease
- Children, Only
- OCTA measurements
-
London, United KingdomGreat Ormond Street Hospital NHS Foundation Trust
Oct 5, 2022
Myopia Trial (CP1, 0.01% atropine)
Not yet recruiting
- Myopia
- CP1
- 0.01% atropine
- (no location specified)
Sep 11, 2023
Accomodation, Refractive Errors, Myopia Trial (1% atropine)
Recruiting
- Accomodation
- +3 more
- 1% atropine
-
Shanghai, Shanghai, ChinaShanghai Eye Diseases Prevention & Treatment Center
Jan 1, 2023
Errors of Refraction Among Primary School Children
Recruiting
- Error, Refractive
- Visual acuity measurement
-
Minya, Minia, EgyptFaculty of Medicine
Oct 7, 2022
The Initiating Factors of Myopia Among Primary and Secondary
Recruiting
- Myopia; Refractive Error
- No intervention
-
Tianjin, Tianjin, ChinaTianjin Eye Hospital
Nov 26, 2022
Mydriasis, Dilation Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)
Completed
- Mydriasis
- Dilation
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle
-
Newport Beach, California
- +14 more
Jun 20, 2022
Myopia Trial in Shenyang (0.01% atropine, 0.9% sodium chloride)
Not yet recruiting
- Myopia
- 0.01% atropine
- 0.9% sodium chloride
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Sep 10, 2023
Myopia, Progressive Trial in Tianjin (Single vision lens, +2D PDL, +3D PDL)
Active, not recruiting
- Myopia, Progressive
- Single vision lens
- +3 more
-
Tianjin, ChinaTianjin Eye Hospital
May 9, 2022
Carious Lesion Trial in Islamabad (Adhesive resin restoration using Titania nanoparticle reinforced bonding agent, Adhesive
Enrolling by invitation
- Carious Lesion
- Adhesive resin restoration using Titania nanoparticle reinforced bonding agent
- Adhesive resin restoration without Titania nanoparticle incorporated bonding agen
-
Islamabad, PakistanSchool of Dentistry, Pakistan Institute of Medical Sciences
Feb 24, 2023
Malignant Tumor Trial in Chendu (EBV immunological agent)
Recruiting
- Malignant Tumor
- EBV immunological agent
-
Chendu, Sichuan, ChinaWest China Hospital
Jan 31, 2023
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- ASP1948
- +2 more
-
New Haven, Connecticut
- +41 more
Jan 10, 2023
Advanced Solid Tumors Trial in Worldwide (ASP1951, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
-
Tucson, Arizona
- +31 more
Jan 10, 2023
Intubation Complication Trial in Karachi (Intravenous morphine)
Completed
- Intubation Complication
- Intravenous morphine
-
Karachi, Sind, PakistanPNS Shifa Hospital
Oct 1, 2023
Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)
Not yet recruiting
- Light Chain (AL) Amyloidosis
- +2 more
- Venetoclax
- Dexamethasone Oral
- (no location specified)
Aug 16, 2023
Superficial Digital Flexor Tendonitis Trial in Zürich (Genipin)
Completed
- Superficial Digital Flexor Tendonitis
-
Zürich, ZH, SwitzerlandEquine surgery, Vetsuisse-Faculty, University of Zurich
Feb 22, 2023
To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
Not yet recruiting
- To Evaluate the Scaling Clinical Study of AAV2-RPE65 Gene Therapy Agent (LX101) in Patients With Congenital Amaurosis (LCA)
- (no location specified)
Aug 29, 2023